A 62-year-old adult with type 2 diabetes has been taking metformin 1,000 mg twice daily for the past 8 years. At a routine follow-up, they report new numbness and tingling in both feet and increased fatigue. Their point-of-care A1C is 7.1%, and a recent nutrition history suggests limited intake of animal-source foods.
What is the most appropriate next step for the diabetes care team?
- A. Ensure the patient has completed a comprehensive foot examination and discuss the risk of diabetes peripheral neuropathy
- B. Recommend increasing dietary protein and iron intake to treat potential nutritional anemia.
- C. Obtain a serum vitamin B12 level and evaluate for deficiency.
- D. Recommend adding another glucose-lowering medication because their A1C is above the ADA Standard of Care target.
Join Dr. Marie Frazzitta for the
Digital Quality Reporting Toolkit: Advanced Strategies for Diabetes Professionals webinar
The U.S. healthcare system is rapidly shifting toward digital quality reporting, transforming how diabetes outcomes are measured, reimbursed, and improved.
In this 1-hour and 15-minute program. Dr. Marie Frazzitta, DNP, FNP‑C, PMHNP, CDCES, MBA, explores how national quality initiatives are modernizing diabetes metrics, including the integration of CGM-derived indicators and the upcoming measure that will track CGM adoption. We’ll also highlight the operational realities of digital reporting and show how DCESs can leverage these trends to expand their impact, strengthen care equity, and become strategic partners in quality improvement and population health.
